Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 6 studies | 24% ± 7% | |
macrophage | 5 studies | 25% ± 10% | |
monocyte | 5 studies | 22% ± 4% | |
type I pneumocyte | 4 studies | 18% ± 3% | |
non-classical monocyte | 3 studies | 23% ± 5% | |
vein endothelial cell | 3 studies | 33% ± 22% |
Insufficient scRNA-seq data for expression of IL15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1982.93 | 653 / 653 | 99% | 6.31 | 599 / 605 |
kidney | 100% | 518.31 | 89 / 89 | 91% | 3.47 | 824 / 901 |
lung | 100% | 858.40 | 577 / 578 | 86% | 2.67 | 995 / 1155 |
esophagus | 99% | 419.43 | 1433 / 1445 | 85% | 2.66 | 155 / 183 |
uterus | 100% | 552.56 | 170 / 170 | 78% | 4.19 | 360 / 459 |
intestine | 100% | 821.70 | 966 / 966 | 75% | 1.82 | 394 / 527 |
stomach | 98% | 428.50 | 351 / 359 | 74% | 1.73 | 211 / 286 |
pancreas | 76% | 169.50 | 248 / 328 | 92% | 2.73 | 163 / 178 |
breast | 100% | 694.01 | 458 / 459 | 67% | 1.54 | 747 / 1118 |
bladder | 100% | 463.81 | 21 / 21 | 63% | 1.87 | 318 / 504 |
prostate | 100% | 444.04 | 244 / 245 | 48% | 0.77 | 240 / 502 |
adrenal gland | 98% | 341.76 | 254 / 258 | 40% | 1.08 | 93 / 230 |
skin | 94% | 305.34 | 1697 / 1809 | 44% | 1.30 | 210 / 472 |
ovary | 53% | 141.47 | 96 / 180 | 78% | 2.84 | 337 / 430 |
liver | 77% | 163.42 | 175 / 226 | 35% | 0.81 | 142 / 406 |
adipose | 100% | 857.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1520.46 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 637.88 | 1316 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 394.89 | 789 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 350.07 | 840 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 5.04 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 2.57 | 25 / 29 |
peripheral blood | 64% | 425.11 | 592 / 929 | 0% | 0 | 0 / 0 |
brain | 20% | 35.97 | 526 / 2642 | 17% | 0.34 | 119 / 705 |
eye | 0% | 0 | 0 / 0 | 8% | 0.10 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0007260 | Biological process | tyrosine phosphorylation of STAT protein |
GO_0035723 | Biological process | interleukin-15-mediated signaling pathway |
GO_0045580 | Biological process | regulation of T cell differentiation |
GO_0001779 | Biological process | natural killer cell differentiation |
GO_0048535 | Biological process | lymph node development |
GO_0030225 | Biological process | macrophage differentiation |
GO_0032819 | Biological process | positive regulation of natural killer cell proliferation |
GO_0007165 | Biological process | signal transduction |
GO_1904100 | Biological process | positive regulation of protein O-linked glycosylation |
GO_0045062 | Biological process | extrathymic T cell selection |
GO_0034105 | Biological process | positive regulation of tissue remodeling |
GO_0007267 | Biological process | cell-cell signaling |
GO_0006955 | Biological process | immune response |
GO_0032825 | Biological process | positive regulation of natural killer cell differentiation |
GO_0001866 | Biological process | NK T cell proliferation |
GO_0001787 | Biological process | natural killer cell proliferation |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0050778 | Biological process | positive regulation of immune response |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0050691 | Biological process | regulation of defense response to virus by host |
GO_0048469 | Biological process | cell maturation |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0042119 | Biological process | neutrophil activation |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005768 | Cellular component | endosome |
GO_0005126 | Molecular function | cytokine receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL15 |
Protein name | Interleukin-15 (IL-15) |
Synonyms | |
Description | FUNCTION: Cytokine that plays a major role in the development of inflammatory and protective immune responses to microbial invaders and parasites by modulating immune cells of both the innate and adaptive immune systems . Stimulates the proliferation of natural killer cells, T-cells and B-cells and promotes the secretion of several cytokines . In monocytes, induces the production of IL8 and monocyte chemotactic protein 1/CCL2, two chemokines that attract neutrophils and monocytes respectively to sites of infection . Unlike most cytokines, which are secreted in soluble form, IL15 is expressed in association with its high affinity IL15RA on the surface of IL15-producing cells and delivers signals to target cells that express IL2RB and IL2RG receptor subunits . Binding to its receptor triggers the phosphorylation of JAK1 and JAK3 and the recruitment and subsequent phosphorylation of signal transducer and activator of transcription-3/STAT3 and STAT5 . In mast cells, induces the rapid tyrosine phosphorylation of STAT6 and thereby controls mast cell survival and release of cytokines such as IL4 (By similarity). . |
Accessions | P40933 ENST00000320650.9 [P40933-1] ENST00000477265.5 [P40933-2] ENST00000529613.5 [P40933-1] ENST00000394159.2 [P40933-2] ENST00000296545.11 [P40933-1] ENST00000514653.5 [P40933-2] |